Covered recipient · General Payments record
ROBERT C BOWEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,555.11
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $512.81 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $169.08 | 10 |
| GlaxoSmithKline, LLC. | $80.48 | 4 |
| ABBVIE INC. | $66.91 | 3 |
| Abbott Laboratories | $62.57 | 3 |
| PFIZER INC. | $57.31 | 3 |
| Verity Pharmaceuticals Inc. | $24.79 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.53 | 1 |
| Astellas Pharma US Inc | $17.35 | 1 |
| Amgen Inc. | $14.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.73 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124907552 | CMS |
| Abbott Laboratories | $21.37 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124907554 | CMS |
| Abbott Laboratories | $22.47 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124907556 | CMS |
| ABBVIE INC. | $32.93 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103355920 | CMS |
| ABBVIE INC. | $16.03 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103355922 | CMS |
| ABBVIE INC. | $17.95 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103355924 | CMS |
| Amgen Inc. | $14.79 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115459525 | CMS |
| Astellas Pharma US Inc | $17.35 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139353531 | CMS |
| Boston Scientific Corporation | $19.53 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092368549 | CMS |
| GlaxoSmithKline, LLC. | $21.92 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116513841 | CMS |
| GlaxoSmithKline, LLC. | $22.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115948416 | CMS |
| GlaxoSmithKline, LLC. | $16.75 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116549403 | CMS |
| GlaxoSmithKline, LLC. | $19.01 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116249356 | CMS |
| Novo Nordisk Inc | $11.05 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097823572 | CMS |
| Novo Nordisk Inc | $10.57 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096715811 | CMS |
| Novo Nordisk Inc | $16.27 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096707031 | CMS |
| Novo Nordisk Inc | $21.39 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621588 | CMS |
| Novo Nordisk Inc | $22.49 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096734565 | CMS |
| Novo Nordisk Inc | $17.08 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096888688 | CMS |
| Novo Nordisk Inc | $18.06 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097046878 | CMS |
| Novo Nordisk Inc | $16.91 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097565158 | CMS |
| Novo Nordisk Inc | $20.31 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096983021 | CMS |
| Novo Nordisk Inc | $14.95 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097260281 | CMS |
| PFIZER INC. | $20.83 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131464523 | CMS |
| PFIZER INC. | $21.75 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131556137 | CMS |
| PFIZER INC. | $14.73 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131553963 | CMS |
| Verity Pharmaceuticals Inc. | $24.79 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080607939 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.